Why the study?
Cardiopulmonary bypass is associated with platelet dysfunction, an important cause of postoperative bleeding whose etiology is not completely understood.
Does protamine administration after cardiopulmonary bypass cause platelet dysfunction?
Does protamine administration after cardiopulmonary bypass cause platelet dysfunction?
Protamine administration after cardiopulmonary bypass appears to play a central mechanistic role in postoperative platelet dysfunction and count decrease.
Answers are grounded in this paper and cite their sources.
Protamine may contribute to post-CPB platelet dysfunction; leaves open whether targeted reversal improves outcomes in cardiac surgery.
Cardiopulmonary bypass (CPB) is associated with platelet dysfunction (PD), an important cause of postoperative bleeding. The etiology of PD is not completely understood. We mapped the platelets' function during CPB to determine the etiology of PD. Platelets activation, measured by procaspase activating compound-1 and P-selectin expression (CD62P), after activation by adenosine diphosphate and thrombin receptor activator peptide, were decreased by protamine. Changes during CPB were insignificant. Platelet-leukocyte aggregation was increased by CPB but not by protamine. Platelet apoptosis marker, annexin V, was increased by protamine. Changes during CPB were insignificant. Our findings demonstrate that protamine given after CPB plays a central role in PD and count decrease.
No takes yet. Share an insight, caveat, or question.
Epstein et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: